Document Detail


Pharmacokinetics and safety of intravitreal caspofungin.
MedLine Citation:
PMID:  25246398     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
PURPOSE: Caspofungin exhibits potent antifungal activities against Candida and Aspergillus species. The elimination rate and retinal toxicity of caspofungin were determined in this study to assess its pharmacokinetics and safety in the treatment of fungal endophthalmitis.
METHODS: Intravitreal injections of 50 μg/0.1 mL of caspofungin were administered to rabbits. Vitreous and aqueous humor levels of caspofungin were determined using high performance liquid chromatography (HPLC) at selected time intervals (10 minutes and 1, 2, 4, 8, 16, 24, and 48 hours) and the half-lives were calculated. Eyes were intravitreally injected with caspofungin to obtain the concentrations of 10 ug/mL, 50 ug/mL, 100 ug/mL, and 200 ug/mL. Electroretinograms were recorded 4 weeks after injections, and the injected eyes were examined histologically.
RESULTS: The concentrations of intravitreal caspofungin at various time points exhibited an exponential decay with a half-life of 6.28 hours. The mean vitreous concentration was 6.06 ± 1.76 μg/mL 1 hour after intravitreal injection, and this declined to 0.47 ± 0.15 μg/mL at 24 hours. The mean aqueous concentration showed undetectable levels at all time points. There were no statistical differences in scotopic a-wave and b-wave responses between control eyes and caspofungin-injected eyes. No focal necrosis or other abnormality in retinal histology was observed.
CONCLUSIONS: Intravitreal caspofungin injection may be considered to be an alternative treatment of fungal endophthalmitis based on its antifungal activity, lower retinal toxicity, and slower elimination rate in the vitreous. More clinical data are needed to determine its potential role as primary therapy for fungal endophthalmitis.
Authors:
Ying-Cheng Shen; Chiao-Ying Liang; Chun-Yuan Wang; Keng-Hung Lin; Min-Yen Hsu; Hon-Leung Yuen; Li-Chen Wei
Related Documents :
19944708 - Anosognosia for cerebral achromatopsia--a longitudinal case study.
23818768 - Patients undergoing long-term treatment with antihypertensive eye drops responded posit...
21397868 - Mindfulness-based stress reduction versus pharmacotherapy for chronic primary insomnia:...
18763448 - Eye color as an indicator of behavior: revisiting worthy and scott.
23493388 - The current state of sleep medicine education in us neurology residency training progra...
984638 - Ocular alkali burns in a large urban area.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-9-22
Journal Detail:
Title:  Antimicrobial agents and chemotherapy     Volume:  -     ISSN:  1098-6596     ISO Abbreviation:  Antimicrob. Agents Chemother.     Publication Date:  2014 Sep 
Date Detail:
Created Date:  2014-9-23     Completed Date:  -     Revised Date:  2014-9-24    
Medline Journal Info:
Nlm Unique ID:  0315061     Medline TA:  Antimicrob Agents Chemother     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2014, American Society for Microbiology. All Rights Reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A Drug Repositioning Screening Identified Pentetic Acid as a Potential Therapeutic Agent for Suppres...
Next Document:  First description of OXA-48 carbapenemase harbored by Escherichia coli and Enterobacter cloacae in a...